BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 22324898)

  • 1. Genetics of immunological and inflammatory components in age-related macular degeneration.
    Tuo J; Grob S; Zhang K; Chan CC
    Ocul Immunol Inflamm; 2012 Feb; 20(1):27-36. PubMed ID: 22324898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxin Signaling in Retinal Pigment and Choroidal Endothelial Cells: Characteristics and Relevance to Age-Related Macular Degeneration.
    Rohrer B
    Adv Exp Med Biol; 2018; 1074():45-51. PubMed ID: 29721926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.
    Whitmore SS; Sohn EH; Chirco KR; Drack AV; Stone EM; Tucker BA; Mullins RF
    Prog Retin Eye Res; 2015 Mar; 45():1-29. PubMed ID: 25486088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes.
    Spraul CW; Lang GE; Grossniklaus HE; Lang GK
    Surv Ophthalmol; 1999 Oct; 44 Suppl 1():S10-32. PubMed ID: 10548114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?
    Camelo S
    Autoimmune Dis; 2014; 2014():532487. PubMed ID: 24876950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of complement in AMD.
    Zipfel PF; Lauer N; Skerka C
    Adv Exp Med Biol; 2010; 703():9-24. PubMed ID: 20711704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruch's Membrane and the Choroid in Age-Related Macular Degeneration.
    Edwards M; Lutty GA
    Adv Exp Med Biol; 2021; 1256():89-119. PubMed ID: 33847999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement system in pathogenesis of AMD: dual player in degeneration and protection of retinal tissue.
    Kawa MP; Machalinska A; Roginska D; Machalinski B
    J Immunol Res; 2014; 2014():483960. PubMed ID: 25276841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
    Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
    Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age-related Macular Degeneration in the Japanese].
    Yoshimura N
    Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited.
    Anderson DH; Radeke MJ; Gallo NB; Chapin EA; Johnson PT; Curletti CR; Hancox LS; Hu J; Ebright JN; Malek G; Hauser MA; Rickman CB; Bok D; Hageman GS; Johnson LV
    Prog Retin Eye Res; 2010 Mar; 29(2):95-112. PubMed ID: 19961953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, innate immunity, and age-related macular degeneration.
    Shaw PX; Stiles T; Douglas C; Ho D; Fan W; Du H; Xiao X
    AIMS Mol Sci; 2016; 3(2):196-221. PubMed ID: 27239555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory biomarkers for AMD.
    Stanton CM; Wright AF
    Adv Exp Med Biol; 2014; 801():251-7. PubMed ID: 24664705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of inflammation in age-related macular degeneration: an up-to-date on genetic landmarks.
    Parmeggiani F; Sorrentino FS; Romano MR; Costagliola C; Semeraro F; Incorvaia C; D'Angelo S; Perri P; De Nadai K; Bonomo Roversi E; Franceschelli P; Sebastiani A; Rubini M
    Mediators Inflamm; 2013; 2013():435607. PubMed ID: 24369445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathological aspects of age-related macular degeneration.
    Patel M; Chan CC
    Semin Immunopathol; 2008 Apr; 30(2):97-110. PubMed ID: 18299834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related macular degeneration: genetic and clinical findings.
    Kokotas H; Grigoriadou M; Petersen MB
    Clin Chem Lab Med; 2011 Apr; 49(4):601-16. PubMed ID: 21175380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CFH Loss in Human RPE Cells Leads to Inflammation and Complement System Dysregulation via the NF-κB Pathway.
    Armento A; Schmidt TL; Sonntag I; Merle DA; Jarboui MA; Kilger E; Clark SJ; Ueffing M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological factors in the pathogenesis and treatment of age-related macular degeneration.
    Kijlstra A; La Heij E; Hendrikse F
    Ocul Immunol Inflamm; 2005 Feb; 13(1):3-11. PubMed ID: 15804763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation in age-related macular degeneration.
    Ozaki E; Campbell M; Kiang AS; Humphries M; Doyle SL; Humphries P
    Adv Exp Med Biol; 2014; 801():229-35. PubMed ID: 24664703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.
    Geerlings MJ; de Jong EK; den Hollander AI
    Mol Immunol; 2017 Apr; 84():65-76. PubMed ID: 27939104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.